An official website of the United States government
The information provided in this table is also available to download (XLSX, 31 KB).
To see how this variable is used with SEER data and the other AYA variable definition, see the AYA Site Recode home page.
| Site Group | ICD-O-3 Histology | ICD-O-3 Primary Site | ICD-O-3 Behavior | Recode value |
|---|---|---|---|---|
| 1. Leukemias and related disorders | ||||
| 1.1 Acute lymphoblastic leukemia | 9826, 9835-9836 | C00.0-C80.9 | 3 | 001 |
| 9687, 9811-9819, 9827, 9837 | C42.0-C42.1, C42.4 | |||
| 1.2 Acute myeloid leukemia | ||||
| 1.2.1 Acute promyelocytic leukemia | 9866 | C00.0-C80.9 | 3 | 002 |
| 1.2.2 Other acute myeloid leukemia | 9840, 9861, 9865, 9867, 9869-9874, 9877-9879, 9891, 9895-9898, 9910-9912, 9920, 9931 | C00.0-C80.9 | 3 | 003 |
| 1.3 Chronic myeloid leukemia | 9863, 9875-9876, 9945-9946 | C00.0-C80.9 | 3 | 004 |
| 1.4 Chronic lymphocytic leukemia | 9823 | C42.0-C42.1, C42.4 | 3 | 005 |
| 1.5 Polycythemia vera | 9950 | C00.0-C80.9 | 3 | 006 |
| 1.6 Essential thrombocythemia | 9962 | C00.0-C80.9 | 3 | 007 |
| 1.7 Primary myelofibrosis | 9961 | C00.0-C80.9 | 3 | 008 |
| 1.8 Myelodysplastic syndrome (MDS) | 9980, 9982-9989, 9991-9993 | C00.0-C80.9 | 3 | 009 |
| 1.9 Other and unspecified leukemias and related disorders | ||||
| 1.9.1 Hairy cell leukemia | 9940 | C00.0-C80.9 | 3 | 010 |
| 1.9.2 Other lymphocytic/lymphoblastic leukemias | 9820, 9831-9834, 9948 | C00.0-C80.9 | 3 | 011 |
| 1.9.3 Other myeloid leukemias | 9860, 9930, 9963-9964 | C00.0-C80.9 | 3 | 012 |
| 1.9.4 Leukemias of mixed phenotype | 9805-9809 | C00.0-C80.9 | 3 | 013 |
| 1.9.5 Mast cell diseases | 9740-9742 | C00.0-C80.9 | 3 | 014 |
| 1.9.6 Other | 9800-9801, 9960, 9965-9968, 9975 | C00.0-C80.9 | 3 | 015 |
| 2. Lymphomas | ||||
| 2.1 Non-Hodgkin lymphomas | ||||
| 2.1.1 Lymphoblastic | 9727-9729 | C00.0-C80.9 | 3 | 016 |
| 9811-9819, 9827, 9837 | C00.0-C41.9, C42.2-C42.3, C44.0-C80.9 | |||
| 2.1.2 Burkitt | 9687 | C00.0-C41.9, C42.2-C42.3, C44.0-C80.9 | 3 | 017 |
| 2.1.3 Diffuse large B-cell (DLBCL) | 9596, 9673, 9680, 9684, 9688-9689, 9712, 9737-9738 | C00.0-C80.9 | 3 | 018 |
| 2.1.4 Primary mediastinal large B-cell excluded from DLBCL | 9679 | C00.0-C80.9 | 3 | 019 |
| 2.1.5 Anaplastic T- and null-cell excluding NK/T-cell | 9700, 9702, 9705, 9708-9709, 9714-9718 | C00.0-C80.9 | 3 | 020 |
| 2.1.6 Follicular | 9690-9691, 9695, 9698 | C00.0-C80.9 | 3 | 021 |
| 2.1.7 NK/T-cell (excluded from anaplastic T-cell) | 9719 | C00.0-C80.9 | 3 | 022 |
| 2.1.8 MALT (mucosa-associated lymphoid tissue) | 9699 | C00.0-C80.9 | 3 | 023 |
| 2.1.9 Other non-Hodgkin lymphoma NOS | 9591, 9670, 9971 | C00.0-C80.9 | 3 | 024 |
| 9823 | C00.0-C41.9, C42.2-C42.3, C44.0-C80.9 | |||
| 2.2 Hodgkin lymphoma | ||||
| 2.2.1 Hodgkin NLP | 9659 | C00.0-C80.9 | 3 | 025 |
| 2.2.2 Hodgkin classic - other | 9650-9655, 9661-9665, 9667 | C00.0-C80.9 | 3 | 026 |
| 2.3 Myeloma | 9731-9734 | C00.0-C80.9 | 3 | 027 |
| 2.4 Cutaneous lymphomas | 9597, 9701, 9725, 9726 | C00.0-C80.9 | 3 | 028 |
| 2.5 Other B- and T-cell lymphomas | 9671, 9675, 9678, 9724, 9735 | C00.0-C80.9 | 3 | 029 |
| 2.6 Other lymphomas - specified and unspecified | ||||
| 2.6.1 Histiocytic and dendritic cell neoplasms | 9749-9759 | C00.0-C80.9 | 3 | 030 |
| 2.6.2 Lymphoma NOS | 9590, 9760-9762, 9764-9769, 9970 | C00.0-C80.9 | 3 | 031 |
| 3. CNS and other intracranial and intraspinal neoplasms+ | ||||
| 3.1 Astroglial and related neoplasms | ||||
| 3.1.1 Oligodendrogliomas | ||||
| 3.1.1.1 Oligodendroglioma - benign/borderline | 9382, 9385, 9450-9451, 9460 | C00.0-C80.9 | 0,1 | 032 |
| 3.1.1.2 Oligodendroglioma - invasive | 9382, 9385, 9450-9451, 9460 | C00.0-C80.9 | 3 | 033 |
| 3.1.2 Glioblastomas/gliofibromas | ||||
| 3.1.2.1 Gliofibroma - benign/borderline | 9440-9442, 9445 | C00.0-C80.9 | 0,1 | 034 |
| 3.1.2.2 Glioblastoma - invasive | 9440-9442, 9445 | C00.0-C80.9 | 3 | 035 |
| 3.1.3 Ependymomas | ||||
| 3.1.3.1 Ependymoma - benign/borderline | 9383, 9391-9394, 9396 | C00.0-C80.9 | 0,1 | 036 |
| 3.1.3.2 Ependymoma - invasive | 9383, 9391-9394, 9396 | C00.0-C80.9 | 3 | 037 |
| 3.1.4 Other astrocytoma/astroglial neoplasms | ||||
| 3.1.4.1 Pilocytic astrocytoma | 9421 | C00.0-C80.9 | 0,1,3 | 038 |
| 3.1.4.2 Other astrocytoma/astroglial - benign/borderline | 9380-9381, 9384, 9400-9401, 9410-9412, 9420, 9424-9425, 9431-9432 | C00.0-C80.9 | 0,1 | 039 |
| 3.1.4.3 Other astrocytoma/astroglial - invasive | 9380-9381, 9384, 9400-9401, 9410-9412, 9420, 9424-9425, 9431-9432 | C00.0-C80.9 | 3 | 040 |
| 3.2 Medulloblastoma and other invasive embryonal CNS tumors | 8963, 9260, 9364-9365, 9470-9478, 9480, 9508 | C70.0-C72.9, C75.1-C75.3 | 3 | 041 |
| 3.3 Neuroblastomas/ganglioneuromas | ||||
| 3.3.1 Ganglioneuroma - benign/borderline | 9490, 9500 | C70.0-C72.9, C75.1-C75.3 | 0,1 | 042 |
| 3.3.2 Neuroblastoma/ganglioneuroblastoma - invasive | 9490, 9500 | C70.0-C72.9, C75.1-C75.3 | 3 | 043 |
| 3.4 Neuronal and mixed neuronal-glial neoplasms | ||||
| 3.4.1 Neuronal and mixed neuronal-glial - benign/borderline | 8680-8693, 9413, 9492-9493, 9505-9506, 9509 | C70.0-C72.9, C75.1-C75.3 | 0,1 | 044 |
| 3.4.2 Neuronal and mixed neuronal-glial - invasive | 8680-8693, 9413, 9492-9493, 9505-9506, 9509 | C70.0-C72.9, C75.1-C75.3 | 3 | 045 |
| 3.5 Meningiomas | ||||
| 3.5.1 Meningioma - benign/borderline | 9530-9539 | C00.0-C80.9 | 0,1 | 046 |
| 3.5.2 Meningioma - invasive | 9530-9539 | C00.0-C80.9 | 3 | 047 |
| 3.6 Choroid plexus neoplasms | ||||
| 3.6.1 Choroid plexus - benign/borderline | 9390 | C70.0-C72.9, C75.1-C75.3 | 0,1 | 048 |
| 3.6.2 Choroid plexus - invasive | 9390 | C70.0-C72.9, C75.1-C75.3 | 3 | 049 |
| 3.7 Craniopharyngiomas | ||||
| 3.7.1 Craniopharyngioma - benign/borderline | 9350-9352 | C70.0-C72.9, C75.1-C75.3 | 0,1 | 050 |
| 3.7.2 Craniopharyngioma - invasive | 9350-9352 | C70.0-C72.9, C75.1-C75.3 | 3 | 051 |
| 3.8 Pituitary neoplasms | ||||
| 3.8.1 Pituitary - benign/borderline | 8040, 8140, 8146, 8246, 8260, 8270-8273, 8280-8281, 8290, 8300, 8310, 8323, 9582 | C70.0-C72.9, C75.2 | 0,1 | 052 |
| 8000-8679, 8700-8709, 8800-8814, 8816-9059, 9110, 9180-9342, 9363-9379, 9386-9389, 9395, 9422, 9443, 9470-9477, 9479-9480, 9491, 9501-9504, 9507, 9510-9522, 9572-9993 | C75.1 | |||
| 3.8.2 Pituitary - invasive | 8040, 8140, 8146, 8246, 8260, 8270-8273, 8280-8281, 8290, 8300, 8310, 8323, 9582 | C70.0-C72.9, C75.2 | 3 | 053 |
| 8000-8361, 8380-8589, 8936, 8940, 8941, 9050-9055, 9363, 9501-9504, 9582 | C75.1 | |||
| 3.9 Pineal neoplasms | ||||
| 3.9.1 Pineal - benign/borderline | 8000-8679, 8700-8709, 8800-8814, 8816-9059, 9110, 9180-9342, 9360-9379, 9386-9389, 9395, 9422, 9443, 9470-9477, 9479-9480, 9491, 9501-9504, 9507, 9510-9522, 9572-9993 | C75.3 | 0,1 | 054 |
| 9360-9362 | C70.0-C72.9, C75.1-C75.2 | |||
| 3.9.2 Pineal - invasive | 8000-8679, 8700-8709, 8827, 8834, 8898, 8905, 8930-8960, 8964-8981, 9020, 9050-9055, 9110, 9360-9363, 9395, 9491, 9501-9504, 9507, 9510-9514, 9582 | C75.3 | 3 | 055 |
| 9360-9362 | C70.0-C72.9, C75.1-C75.2 | |||
| 3.10 Other and unspecified CNS neoplasms | ||||
| 3.10.1 Other and unspecified CNS - benign/borderline | 8000-8039, 8041-8139, 8141-8145, 8147-8245, 8247-8259, 8261-8265, 8311-8322, 8324-8679, 8700-8709, 8800-8814, 8816-9059, 9110, 9180-9342, 9363-9379, 9386-9389, 9395, 9422, 9443, 9470-9477, 9479-9480, 9491, 9501-9504, 9507, 9510-9522, 9572-9581, 9583-9993 | C70.0-C72.9, C75.2 | 0,1 | 056 |
| 8720-8799, 9423, 9430, 9444 | C70.0-C72.9, C75.1-C75.3 | |||
| 3.10.2 Other and unspecified CNS - invasive | 8000-8005, 8935-8936, 9050-9055, 9363, 9501-9504 | C70.0-C72.9, C75.2 | 3 | 057 |
| 9423, 9430, 9444 | C00.0-C80.9 | |||
| 4. Sarcomas@ | ||||
| 4.1 Osteosarcoma | 9180-9187, 9192-9210 | C00.0-C80.9 | 3 | 058 |
| 4.2 Chondrosarcoma | 9220-9221, 9230-9231, 9240, 9242-9243 | C00.0-C80.9 | 3 | 059 |
| 4.3 Ewing family of tumors | ||||
| 4.3.1 Bone | 9260, 9364-9365, 9473 | C40.0-C41.9 | 3 | 060 |
| 4.3.2 Soft tissue | 9260, 9364-9365, 9473 | C00.0-C39.9, C42.0-C69.9, C73.0-C75.0, C75.4-C80.9 | 3 | 061 |
| 4.4 Fibromatous neoplasms | ||||
| 4.4.1 Myxofibrosarcoma | 8811 | C00.0-C80.9 | 3 | 062 |
| 4.4.2 Malignant fibrous histiocytoma$ | 8830-8831, 8835-8836 | C00.0-C80.9 | 3 | 063 |
| 4.4.3 Other fibromatous neoplasms | 8810, 8813-8814, 8820-8826, 8832-8833, 9252 | C00.0-C80.9 | 3 | 064 |
| 4.5 Liposarcoma | 8850-8881 | C00.0-C80.9 | 3 | 065 |
| 4.6 Synovial sarcoma | 9040-9043 | C00.0-C80.9 | 3 | 066 |
| 4.7 Leiomyosarcoma | 8890-8893 | C00.0-C80.9 | 3 | 067 |
| 4.8 Rhabdomyosarcoma | 8900-8904, 8910, 8912, 8920-8921 | C00.0-C80.9 | 3 | 068 |
| 4.9 Gastrointestinal stromal tumor, malignant | 8936 | C00.0-C69.9, C73.0-C75.0, C75.4-C80.9 | 3 | 069 |
| 4.10 Spindle cell sarcoma | 8801 | C00.0-C39.9, C42.0-C80.9 | 3 | 070 |
| 4.11 Epithelioid sarcoma | 8804 | C00.0-C80.9 | 3 | 071 |
| 4.12 Desmoplastic small round cell tumor | 8806 | C00.0-C39.9, C42.0-C80.9 | 3 | 072 |
| 4.13 Chordoma | 9370-9379 | C00.0-C80.9 | 3 | 073 |
| 4.14 Giant cell sarcoma | 8802 | C00.0-C39.9, C42.0-C80.9 | 3 | 074 |
| 4.15 Other soft tissue sarcomas | 8840-8849, 8894-8897, 8982-8983, 8990-8991, 9044-9045, 9251, 9580-9581 | C00.0-C80.9 | 3 | 075 |
| 8935 | C00.0-C69.9, C73.0-C75.0, C75.4-C80.9 | |||
| 8800, 8803, 8805 | C00.0-C39.9, C42.0-C80.9 | |||
| 4.16 Other bone tumors | 8812, 9250, 9261, 9270-9342 | C00.0-C80.9 | 3 | 076 |
| 8000-8005, 8800-8803, 8805-8806 | C40.0-C41.9 | |||
| 5. Blood and lymphatic vessel tumors | ||||
| 5.1 Benign blood and lymphatic vessel tumors - CNS | ||||
| 5.1.1 Hemangioblastoma and tufted hemangioma | 9161 | C70.0-C72.9, C75.1-C75.3 | 0,1 | 077 |
| 5.1.2 Cavernous hemangioma | 9121 | C70.0-C72.9, C75.1-C75.3 | 0,1 | 078 |
| 5.1.3 Other | 8710-8714, 8815, 9120, 9122-9160, 9170-9175 | C70.0-C72.9, C75.1-C75.3 | 0,1 | 079 |
| 5.2 Malignant blood and lymphatic vessel tumors - all sites | ||||
| 5.2.1 Kaposi sarcoma | 9140 | C00.0-C80.9 | 3 | 080 |
| 5.2.2 Other | 8710-8714, 8815, 9120-9138, 9141-9175 | C00.0-C80.9 | 3 | 081 |
| 6. Nerve sheath tumors | ||||
| 6.1 Benign - CNS | ||||
| 6.1.1 Neurilemmoma | 9560 | C70.0-C72.9, C75.1-C75.3 | 0,1 | 082 |
| 6.1.2 Other | 9540-9550, 9561-9571 | C70.0-C72.9, C75.1-C75.3 | 0,1 | 083 |
| 6.2 Malignant | ||||
| 6.2.1 MPNST (Malignant peripheral nerve sheath tumor) | ||||
| 6.2.1.1 CNS | 9540-9542 | C70.0-C72.9, C75.1-C75.3 | 3 | 084 |
| 6.2.1.2 Peripheral | 9540-9542 | C00.0-C69.9, C73.0-C75.0, C75.4-C80.9 | 3 | 085 |
| 6.2.2 Other | 9543-9571 | C00.0-C80.9 | 3 | 086 |
| 7. Gonadal and related tumors | ||||
| 7.1 Testis | ||||
| 7.1.1 Germ cell and trophoblastic | ||||
| 7.1.1.1 Seminoma | 9060-9064 | C62.0-C62.9 | 3 | 087 |
| 7.1.1.2 Embryonal carcinoma | 9070 | C62.0-C62.9 | 3 | 088 |
| 7.1.1.3 Endodermal sinus (yolk sac tumor) | 9071 | C62.0-C62.9 | 3 | 089 |
| 7.1.1.4 Teratoma | 9080-9084 | C62.0-C62.9 | 3 | 090 |
| 7.1.1.5 Mixed germ cell | 9085, 9086 | C62.0-C62.9 | 3 | 091 |
| 7.1.1.6 Choriocarcinoma and other trophoblastic | 9100-9105 | C62.0-C62.9 | 3 | 092 |
| 7.1.1.7 Other | 9065, 9072 | C62.0-C62.9 | 3 | 093 |
| 7.1.2 Non-germ cell | ||||
| 7.1.2.1 Carcinoma | 8010-8589 | C62.0-C62.9 | 3 | 094 |
| 7.1.2.2 Sex cord | 8590-8671 | C62.0-C62.9 | 3 | 095 |
| 7.2 Ovary | ||||
| 7.2.1 Germ cell and trophoblastic | ||||
| 7.2.1.1 Teratoma | 9070, 9072-9084 | C56.9 | 3 | 096 |
| 7.2.1.2 Dysgerminoma | 9060 | C56.9 | 3 | 097 |
| 7.2.1.3 Yolk sac | 9071 | C56.9 | 3 | 098 |
| 7.2.1.4 Mixed germ cell | 9085, 9086 | C56.9 | 3 | 099 |
| 7.2.1.5 Other germ cell and trophoblastic | 9061-9065, 9090-9091, 9100-9105 | C56.9 | 3 | 100 |
| 7.2.2 Non-germ cell | ||||
| 7.2.2.1 Carcinoma | ||||
| 7.2.2.1.1 Adenocarcinoma | ||||
| 7.2.2.1.1.1 Clear cell adenocarcinoma | 8310 | C56.9 | 3 | 101 |
| 7.2.2.1.1.2 Cystadenocarcinoma | 8440-8474 | C56.9 | 3 | 102 |
| 7.2.2.1.1.3 Mixed cell adenocarcinoma | 8323 | C56.9 | 3 | 103 |
| 7.2.2.1.1.4 Mucinous adenocarcinoma | 8480-8482 | C56.9 | 3 | 104 |
| 7.2.2.1.1.5 Endometrioid | 8380-8383 | C56.9 | 3 | 105 |
| 7.2.2.1.1.6 Other adenocarcinoma | 8140-8231, 8250-8309, 8311-8322, 8324-8379, 8384, 9110 | C56.9 | 3 | 106 |
| 7.2.2.1.2 Other carcinoma | 8010-8139, 8240-8249, 8390-8439, 8483-8589 | C56.9 | 3 | 107 |
| 7.2.2.2 Sex cord and other specialized gonadal | 8590-8671 | C56.9 | 3 | 108 |
| 7.3 Germ cell and trophoblastic - CNS | 9060-9065, 9070-9073, 9080-9085, 9090-9091, 9100-9105 | C70.0-C72.9, C75.1-C75.3 | 0,1,3 | 109 |
| 7.4 Germ cell and trophoblastic excluding CNS, ovary, testis | 9060-9065, 9070-9073, 9080-9085, 9090-9091, 9100-9105 | C00.0-C56.8, C57.0-C61.9, C63.0-C69.9, C73.0-C75.0, C75.4-C80.9 | 3 | 110 |
| 7.5 Non-germ cell specified tumors excluding CNS, ovary, testis | 8590-8671 | C00.0-C55.9, C57.0-C61.9, C63.0-C69.9, C73.0-C75.0, C75.4-C80.9 | 3 | 111 |
| 7.6 Fibroepithelial including Brenner excluding breast phyllodes | 9000-9019, 9021-9030 | C00.0-C80.9 | 3 | 112 |
| 8. Melanoma - malignant | ||||
| 8.1 Superficial spreading/low cumulative sun damage melanoma | 8743 | C00.0-C80.9 | 3 | 113 |
| 8.2 Nodular melanoma | 8721 | C00.0-C80.9 | 3 | 114 |
| 8.3 Other malignant | 8720, 8722-8742, 8744-8790 | C00.0-C80.9 | 3 | 115 |
| 9. Carcinomas# | ||||
| 9.1 Thyroid carcinoma | ||||
| 9.1.1 Medullary | 8345, 8510-8513 | C73.9 | 3 | 116 |
| 9.1.2 Hurthle cell carcinoma | 8290 | C73.9 | 3 | 117 |
| 9.1.3 Papillary | 8050-8053, 8260, 8341-8344, 8503-8507 | C73.9 | 3 | 118 |
| 9.1.4 Follicular | 8330-8335, 8339 | C73.9 | 3 | 119 |
| 9.1.5 Papillary with follicular variant | 8340 | C73.9 | 3 | 120 |
| 9.1.6 Other | 8010-8046, 8054-8257, 8261-8289, 8291-8325, 8336-8337, 8346-8502, 8508-8509, 8514-8589 | C73.9 | 3 | 121 |
| 9.2 Other carcinoma of head and neck | ||||
| 9.2.1 Nasopharyngeal carcinoma | ||||
| 9.2.1.1 Nasopharyngeal carcinoma - squamous | 8050-8089 | C11.0-C11.9 | 3 | 122 |
| 9.2.1.2 Nasopharyngeal carcinoma - other | 8010-8049, 8090-8589 | C11.0-C11.9 | 3 | 123 |
| 9.2.2 Oral cavity, lip, and pharynx | ||||
| 9.2.2.1 Oral cavity, lip, and pharynx - squamous | 8050-8089 | C00.0-C06.9, C09.0-C10.9, C12.0-C14.8 | 3 | 124 |
| 9.2.2.2 Oral cavity, lip, and pharynx - mucoepidermoid | 8430-8439 | C00.0-C06.9, C09.0-C10.9, C12.0-C14.8 | 3 | 125 |
| 9.2.2.3 Oral cavity, lip, and pharynx - other | 8010-8049, 8090-8429, 8440-8589 | C00.0-C06.9, C09.0-C10.9, C12.0-C14.8 | 3 | 126 |
| 9.2.3 Salivary gland | ||||
| 9.2.3.1 Salivary gland - acinar | 8550-8552 | C07.9-C08.1, C08.8-C08.9 | 3 | 127 |
| 9.2.3.2 Salivary gland - other malignant | 8010-8543, 8560-8589 | C07.9-C08.1, C08.8-C08.9 | 3 | 128 |
| 9.2.4 Other carcinoma of head and neck | 8010-8589 | C30.0-C32.9, C76.0 | 3 | 129 |
| 9.3 Carcinoma of gastrointestinal tract | ||||
| 9.3.1 Carcinoma of esophagus | 8010-8589 | C15.0-C15.9 | 3 | 130 |
| 9.3.2 Carcinoma of stomach | ||||
| 9.3.2.1 Stomach - neuroendocrine | ||||
| 9.3.2.1.1 Neuroendocrine tumor (NET) | 8240-8245, 8248-8249 | C16.0-C16.9 | 3 | 131 |
| 9.3.2.1.2 Neuroendocrine carcinoma (NEC) | 8013, 8041-8045, 8246 | C16.0-C16.9 | 3 | 132 |
| 9.3.2.2 Stomach - signet ring | 8490 | C16.0-C16.9 | 3 | 133 |
| 9.3.2.3 Stomach - other adenocarcinoma | 8140-8239, 8250-8489, 8491-8579 | C16.0-C16.9 | 3 | 134 |
| 9.3.2.4 Stomach - other invasive | 8010-8012, 8014-8040, 8046-8139, 8247, 8580-8589 | C16.0-C16.9 | 3 | 135 |
| 9.3.3 Carcinoma of small intestine | ||||
| 9.3.3.1 Small intestine - neuroendocrine | ||||
| 9.3.3.1.1 NET | 8240-8245, 8248-8249 | C17.0-C17.9 | 3 | 136 |
| 9.3.3.1.2 NEC | 8013, 8041-8045, 8246 | C17.0-C17.9 | 3 | 137 |
| 9.3.3.2 Small intestine - other | 8010-8012, 8014-8040, 8046-8239, 8247, 8250-8589 | C17.0-C17.9 | 3 | 138 |
| 9.3.4 Carcinoma of colon | ||||
| 9.3.4.1 Appendix | ||||
| 9.3.4.1.1 NET | 8240-8245, 8248-8249 | C18.1 | 3 | 139 |
| 9.3.4.1.2 NEC | 8013, 8041-8045, 8246 | C18.1 | 3 | 140 |
| 9.3.4.1.3 Appendix - other | 8010-8012, 8014-8040, 8046-8239, 8247, 8250-8589 | C18.1 | 3 | 141 |
| 9.3.4.2 Colon excluding appendix | ||||
| 9.3.4.2.1 Colon excluding appendix - neuroendocrine | ||||
| 9.3.4.2.1.1 NET | 8240-8245, 8248-8249 | C18.0, C18.2-C18.9 | 3 | 142 |
| 9.3.4.2.1.2 NEC | 8013, 8041-8045, 8246 | C18.0, C18.2-C18.9 | 3 | 143 |
| 9.3.4.2.2 Colon excluding appendix - adenocarcinoma | 8140-8239, 8250-8579 | C18.0, C18.2-C18.9 | 3 | 144 |
| 9.3.4.2.3 Colon excluding appendix - other | 8010-8012, 8014-8040, 8046-8139, 8247, 8580-8589 | C18.0, C18.2-C18.9 | 3 | 145 |
| 9.3.5 Carcinoma of rectum | ||||
| 9.3.5.1 Rectum - neuroendocrine | ||||
| 9.3.5.1.1 NET | 8240-8245, 8248-8249 | C19.9-C20.9 | 3 | 146 |
| 9.3.5.1.2 NEC | 8013, 8041-8045, 8246 | C19.9-C20.9 | 3 | 147 |
| 9.3.5.2 Rectum - adenocarcinoma | 8140-8239, 8250-8579 | C19.9-C20.9 | 3 | 148 |
| 9.3.5.3 Rectum - other | 8010-8012, 8014-8040, 8046-8139, 8247, 8580-8589 | C19.9-C20.9 | 3 | 149 |
| 9.3.6 Carcinoma of anus | ||||
| 9.3.6.1 Anus - squamous | 8050-8089 | C21.0-C21.8 | 3 | 150 |
| 9.3.6.2 Anus - other | 8010-8046, 8090-8589 | C21.0-C21.8 | 3 | 151 |
| 9.3.7 Carcinoma of liver and intrahepatic bile ducts (IBD) | ||||
| 9.3.7.1 Liver and IBD - cholangiocarcinoma | 8160-8169 | C22.0-C22.1 | 3 | 152 |
| 9.3.7.2 Liver and IBD - hepatocellular carcinoma | 8170-8189 | C22.0-C22.1 | 3 | 153 |
| 9.3.7.3 Liver and IBD - other | 8010-8159, 8190-8589 | C22.0-C22.1 | 3 | 154 |
| 9.3.8 Carcinoma of gallbladder and other extrahepatic biliary | 8010-8589 | C23.9-C24.9 | 3 | 155 |
| 9.3.9 Carcinoma of pancreas | ||||
| 9.3.9.1 Pancreas - neuroendocrine | ||||
| 9.3.9.1.1 NET | 8150, 8240, 8249 | C25.0-C25.9 | 3 | 156 |
| 9.3.9.1.2 NEC | 8013, 8041-8045, 8246 | C25.0-C25.9 | 3 | 157 |
| 9.3.9.1.3 Neuroendocrine - other | 8151-8153, 8155-8156, 8241-8245, 8248 | C25.0-C25.9 | 3 | 158 |
| 9.3.9.2 Pancreas - adenocarcinoma | 8140-8149, 8160-8239, 8250-8579 | C25.0-C25.9 | 3 | 159 |
| 9.3.9.3 Pancreas - other | 8010-8012, 8014-8040, 8046, 8050-8139, 8154, 8157, 8247, 8580-8589 | C25.0-C25.9 | 3 | 160 |
| 9.3.10 Other carcinoma of gastrointestinal tract | 8010-8589 | C26.0-C26.9 | 3 | 161 |
| 9.4 Carcinoma of lung, bronchus, and trachea | ||||
| 9.4.1 Small cell carcinoma - neuroendocrine carcinoma (NEC) | 8041-8045 | C33.0-C34.9 | 3 | 162 |
| 9.4.2 Non-small cell carcinoma | ||||
| 9.4.2.1 Non-small cell - adenocarcinoma | 8140-8239, 8250-8579 | C33.0-C34.9 | 3 | 163 |
| 9.4.2.2 Non-small cell - neuroendocrine | ||||
| 9.4.2.2.1 Non-small cell NET | 8240-8245, 8248-8249 | C33.0-C34.9 | 3 | 164 |
| 9.4.2.2.2 Non-small cell NEC | 8013, 8246 | C33.0-C34.9 | 3 | 165 |
| 9.4.2.3 Non-small cell - other | 8010-8012, 8014-8040, 8046-8139, 8247, 8580-8589, 9050-9059 | C33.0-C34.9 | 3 | 166 |
| 9.5 Carcinoma of skin (if collected) | 8010-8589 | C44.0-C44.9 | 3 | 167 |
| 9.6 Carcinoma of breast | ||||
| 9.6.1 Breast - infiltrating duct | 8500, 8522-8523 | C50.0-C50.9 | 3 | 168 |
| 9.6.2 Breast - adenocarcinoma | 8140-8230, 8250-8313, 8321-8323, 8360-8384, 8401-8402, 8410-8420, 8440-8450, 8460-8490, 8503-8504, 8509, 8550-8552, 8570-8574 | C50.0-C50.9 | 3 | 169 |
| 9.6.3 Breast - lobular | 8520, 8524 | C50.0-C50.9 | 3 | 170 |
| 9.6.4 Breast - phyllodes | 9020 | C50.0-C50.9 | 3 | 171 |
| 9.6.5 Breast - medullary | 8510-8513 | C50.0-C50.9 | 3 | 172 |
| 9.6.6 Breast - Paget | 8540-8543 | C50.0-C50.9 | 3 | 173 |
| 9.6.7 Breast - ductal | 8507, 8514, 8521 | C50.0-C50.9 | 3 | 174 |
| 9.6.8 Breast - metaplastic | 8575 | C50.0-C50.9 | 3 | 175 |
| 9.6.9 Breast - inflammatory | 8530 | C50.0-C50.9 | 3 | 176 |
| 9.6.10 Breast - other | 8010-8131, 8231-8249, 8314-8320, 8324-8350, 8390-8400, 8403-8409, 8430, 8452-8454, 8501-8502, 8505-8506, 8508, 8525, 8560-8562, 8580-8589 | C50.0-C50.9 | 3 | 177 |
| 9.7 Carcinoma of genital sites excluding ovary and testis | ||||
| 9.7.1 Carcinoma of uterine cervix | ||||
| 9.7.1.1 Cervix - squamous | 8050-8089 | C53.0-C53.9 | 3 | 178 |
| 9.7.1.2 Cervix - adenosquamous | 8560-8570 | C53.0-C53.9 | 3 | 179 |
| 9.7.1.3 Cervix - adenocarcinoma | 8140-8559, 8571-8579 | C53.0-C53.9 | 3 | 180 |
| 9.7.1.4 Cervix - other | 8010-8049, 8090-8139, 8580-8589 | C53.0-C53.9 | 3 | 181 |
| 9.7.2 Corpus uteri | ||||
| 9.7.2.1 Corpus uteri - adenocarcinoma | ||||
| 9.7.2.1.1 Corpus uteri - endometrioid | 8380-8383 | C54.0-C55.9 | 3 | 182 |
| 9.7.2.1.2 Corpus uteri - other adenocarcinoma | 8140-8379, 8384-8579 | C54.0-C55.9 | 3 | 183 |
| 9.7.2.2 Corpus uteri - other | 8010-8139, 8580-8589, 8930-8931, 8950 | C54.0-C55.9 | 3 | 184 |
| 9.7.3 Carcinoma of vulva and vagina | 8010-8589 | C51.0-C51.9, C52.9 | 3 | 185 |
| 9.7.4 Carcinoma of penis | 8010-8589 | C60.0-C60.9 | 3 | 186 |
| 9.7.5 Carcinoma of prostate | 8010-8589 | C61.9 | 3 | 187 |
| 9.7.6 Other genital | 8010-8589 | C57.0-C57.9, C58.9, C63.0-C63.9 | 3 | 188 |
| 9.8 Carcinoma of urinary tract | ||||
| 9.8.1 Carcinoma of kidney | ||||
| 9.8.1.1 Kidney - adenocarcinoma | ||||
| 9.8.1.1.1 Kidney - renal cell | 8310-8319 | C64.9 | 3 | 189 |
| 9.8.1.1.2 Kidney - other adenocarcinoma | 8140-8309, 8320-8579 | C64.9 | 3 | 190 |
| 9.8.1.2 Kidney - other | 8010-8139, 8580-8589 | C64.9 | 3 | 191 |
| 9.8.2 Carcinoma of bladder | ||||
| 9.8.2.1 Urinary bladder - transitional cell carcinoma | 8120-8139 | C67.0-C67.9 | 3 | 192 |
| 9.8.2.2 Urinary bladder - other carcinoma | 8010-8119, 8140-8589 | C67.0-C67.9 | 3 | 193 |
| 9.8.3 Other urinary | 8010-8589 | C65.9, C66.9, C68.0-C68.9 | 3 | 194 |
| 9.9 Other invasive carcinomas | ||||
| 9.9.1 Adrenocortical carcinoma | 8010-8589 | C74.0-C74.9 | 3 | 195 |
| 9.9.2 Unknown primary | 8010-8589 | C80.9 | 3 | 196 |
| 9.9.3 Thymic carcinoma | 8010-8589 | C37.9 | 3 | 197 |
| 9.9.4 Carcinoma of other and ill-defined sites | 8010-8589 | C38.0-C42.4, C47.0-C49.9, C69.0-C69.9, C75.0, C75.4-C75.9, C76.1-C80.8 | 3 | 198 |
| 10. Miscellaneous specified neoplasms | ||||
| 10.1 Other pediatric and embryonal tumors | ||||
| 10.1.1 Wilms tumor | 8959-8960 | C00.0-C69.9, C73.0-C75.0, C75.4-C80.9 | 3 | 199 |
| 10.1.2 Olfactory and other non-CNS neuroblastomas | 9490, 9500 | C00.0-C69.9, C73.0-C75.0, C75.4-C80.9 | 3 | 200 |
| 9520-9522 | C00.0-C80.9 | |||
| 10.1.3 Other neuronal and embryonal non-CNS tumors | 8963-8964, 8970-8973, 8981, 9501-9519, 9523 | C00.0-C69.9, C73.0-C75.0, C75.4-C80.9 | 3 | 201 |
| 10.2 Other specified tumors | ||||
| 10.2.1 Paraganglioma - non-CNS | 8680-8693, 8700 | C00.0-C69.9, C73.0-C75.0, C75.4-C80.9 | 3 | 202 |
| 10.2.2 Other specified neoplasms | 8932-8934, 8937-8939, 8941-8949, 8951, 8980, 9110 | C00.0-C56.8, C57.0-C69.9, C73.0-C75.0, C75.4-C80.9 | 3 | 203 |
| 8932-8934, 8937-8939, 8941-8949, 8951, 8980 | C56.9 | |||
| 9050-9055 | C00.0-C32.9, C35.0-C69.9, C73.0-C75.0, C75.4-C80.9 | |||
| 8930-8931,8950 | C00.0-C53.9, C56.0-C69.9, C73.0-C75.0, C75.4-C80.9 | |||
| 8370-8375 | C75.1 | |||
| 11. Unspecified malignant neoplasms except CNS | 8000-8005 | C00.0-C39.9, C42.0-C69.9, C73.0-C75.0, C75.4-C80.9 | 3 | 204 |
| 8940 | C00.0-C69.9, C73.0-C75.0, C75.4-C80.9 | |||
| A. In situ | ||||
| A.1 Melanoma in situ (if collected) | ||||
| A.1.1 Superficial spreading melanoma in situ | 8743 | C00.0-C80.9 | 2 | 205 |
| A.1.2 Lentigo maligna | 8742 | C00.0-C80.9 | 2 | 206 |
| A.1.3 Other in situ melanoma | 8720-8741, 8744-8790 | C00.0-C80.9 | 2 | 207 |
| A.2 Colon including appendix - in situ | 8000-8719, 8800-9589 | C18.0-C18.9 | 2 | 208 |
| A.3 Rectum - in situ | 8000-8719, 8800-9589 | C19.9-C20.9 | 2 | 209 |
| A.4 Anus - in situ | 8000-8719, 8800-9589 | C21.0-C21.8 | 2 | 210 |
| A.5 Breast - in situ | 8000-8719, 8800-9589 | C50.0-C50.9 | 2 | 211 |
| A.6 Cervix uteri - in situ (not collected by some registries) | 8000-8719, 8800-9589 | C53.0-C53.9 | 2 | 212 |
| A.7 Ovary - in situ | 8000-8719, 8800-9589 | C56.9 | 2 | 213 |
| A.8 Vulva and vagina - in situ | 8000-8719, 8800-9589 | C51.0-C51.9, C52.9 | 2 | 214 |
| A.9 Penis - in situ | 8000-8719, 8800-9589 | C60.0-C60.9 | 2 | 215 |
| A.10 Prostate in situ including PIN III* | 8000-8719, 8800-9589 | C61.9 | 2 | 216 |
| A.11 Urinary bladder - in situ | 8000-8719, 8800-9589 | C67.0-C67.9 | 2 | 217 |
| A.12 Other in situ | 8000-8719, 8800-9589 | C00.0-C17.9, C22.0-C49.9, C54.0-C55.9, C57.0-C58.9, C62.0-C66.9, C68.0-C80.9 | 2 | 218 |
| Unclassified | 999 | |||
Note: Except for CNS, behavior codes 0 and 1 are not collected by many cancer registries.
+ CNS germ cell tumor: see category 7.3 under Gonadal and Related Tumors
# excludes in situ; includes carcinoma histology codes which may not occur for a particular site
* Prostatic intraepithelial neoplasia grade III - not collected by all
@ Kaposi sarcoma: see category 5.2.1
$ Undifferentiated pleomorphic sarcoma
